Prostate cancer-associated SEs are frequently bound and activated by bromodomain-containing protein 4 (BRD4) [65], a transcriptional and epigenetic regulator with a prominent function in prostate cancer progression [66]. The gene discussed is BRD4; the disease is prostate cancer.